Opaleye Management Inc. Q2 2019 Filing

Filed August 14, 2019

Portfolio Value

$328.1M

Holdings

43

Report Date

Q2 2019

Filing Type

13F-HR

All Holdings (43 positions)

#StockSharesValue% PortfolioType
1
CDXSCODEXIS INC
1,350,000$24.9M7.58%
2
HARROW HEALTH
2,210,000$19.2M5.86%
3
AXGNAXOGEN INC
900,000$17.8M5.43%
4
EPIZYME INC
1,365,000$17.1M5.22%
5
QUREUNIQURE NV
205,000$16.0M4.88%
6
ODONATE THERAPEUTICS INC
425,000$15.6M4.75%
7
OCULOCULAR THERAPEUTIX INC
2,950,000$13.0M3.96%
8
AMRNAMARIN CORP PLC
645,000$12.5M3.81%
9
2L9BLUEPRINT MEDICINES CORP
125,000$11.8M3.59%
10
CERECOR INC
2,185,536$11.2M3.41%
11
AUDENTES THERAPEUTICS INC
280,000$10.6M3.23%
12
PTCTPTC THERAPEUTICS INC
226,388$10.2M3.10%
13
CYTKCYTOKINETICS
900,000$10.1M3.09%
14
TGTXTG THERAPEUTICS INC
1,150,000$9.9M3.03%
15
EIDOS THERAPEUTICS INC
305,550$9.5M2.89%
16
LXRXLEXICON PHARMACEUTICALS INC
1,480,000$9.3M2.84%
17
ETONETON PHARMACEUTICALS INC
1,075,000$8.5M2.59%
18
MAGENTA THERAPEUTICS INC
535,000$7.9M2.41%
19
1T7TRICIDA INC
195,000$7.7M2.35%
20
DCPHEURDECIPHERA PHARMACEUTICALS IN
310,000$7.0M2.13%
21
FGENEURFIBROGEN INC
150,000$6.8M2.07%
22
BIOHAVEN PHARMACEUTICAL HLDG
150,000$6.6M2.00%
23
CMRXEURCHIMERIX INC
1,470,000$6.3M1.94%
24
XOMAXOMA CORP DEL
400,000$5.9M1.81%
25
AVENUE THERAPEUTICS INC
930,000$5.9M1.79%
26
IRWDIRONWOOD PHARMACEUTICAL INC
525,400$5.7M1.75%
27
ACADACADIA PHARMACEUTICALS INC
200,000$5.3M1.63%
28
ARVNARVINAS INC
220,000$4.8M1.47%
29
VERMILLION INC
4,250,000$3.8M1.15%
30
ZYMEWORKS INC
170,000$3.7M1.14%
31
STRONGBRIDGE BIOPHARMA PLC
1,140,000$3.6M1.09%
32
FORTRESS BIOTECH INC
2,365,000$3.5M1.08%
33
VKTXVIKING THERAPEUTICS INC
400,000$3.3M1.01%
34
AIMMUNE THERAPEUTICS INC
130,000$2.7M0.83%
35
AQSTAQUESTIVE THERAPEUTICS INC
590,000$2.5M0.76%
36
SYNTHORX INC
157,600$2.1M0.65%
37
RA PHARMACEUTICALS INC
51,000$1.5M0.47%
38
FRXFENNEC PHARMACEUTICALS INC
295,000$1.2M0.36%
39
ARQULE INC
100,000$1.1M0.34%
40
CRNXCRINETICS PHARMACEUTICALS INC
36,000$900K0.27%
41
PROTALIX BIOTHERAPEUTICS INC
1,000,000$469K0.14%
42
AZURRX BIOPHARMA INC
145,000$247K0.08%
43
BIOLINERX LTD (Does not reflect a reverse stock split effectuated after June 30, 2019)
250,000$91K0.03%